Plant extraction property will meet the international business standard next year

December 18, Business Association news standard problem has always been the weakness of the planting industry in China The reporter recently confirmed from China Pharmaceutical (600056, Guba) health care products import and Export Chamber of commerce that the first batch of international business standards for plant extract will be published as soon as March 2013, and the plant extract industry will show a new look on the international stage in the future It is reported that the products of 11 plant extract standards to be issued are: bilberry extract, green tea extract, Ginkgo biloba extract, grape seed extract, silymarin extract, Polygonum cuspidatum extract, Centella asiatica extract, willow branch extract, ginseng extract, hesperidin and rutin extract Liu Zhanglin, vice president of China Chamber of Commerce for the import and export of medical and health products, told reporters that the relevant indicators and determination methods of the international business standards for plant extracts formulated this time will be combined with reference to the international standards or Pharmacopoeia provisions, applicable to the export of products to the European Union, the United States, Japan and other international markets, and more variety standards will be formulated in the future By 2017, global sales of plant supplements and herbal medicines will reach US $107 billion, according to standard poverty data In recent years, the export of plant extracts in China has been on the rise But the beautiful figures can not cover up the defects of the plant extract industry in China Han Yi, director of the import and export food safety administration of AQSIQ, lamented at the 2012 Forum on improving the international competitiveness of China's plant extract industry held in October: "at present, the country has no unified and perfect policies, relevant laws and regulations are not perfect, and the country's positioning for the plant extract industry is not clear, so that many plant extract products do not have a unified quality standard These soft environments restrict the development of plant extraction industry in China For a long time, China's extract industry has been highly dependent on the international market, with 80% of its products exported to foreign countries As the largest consumer region of plant supplements and herbal medicines in the world, Europe and North America, 70% of its plant raw materials come from China With the increase of the market, the regulations of herbal supplements and drugs in European and American countries are increasingly strict It is the common aspiration of the industry to establish a complete and standardized industry standard system for more plant extract varieties, and to establish a unified international standard as soon as possible to meet the needs of the international market Zhang Chengcheng, general manager of Xi'an Haotian Bioengineering Technology Co., Ltd and President of China plant extract association, said: "after the international financial crisis, the three major markets in Europe, the United States and Japan have shown a strong localization trend, putting forward new requirements for the price, cost and safety of plant extract products." For example, the United States and Europe, as the main export markets of plant extracts in China, together account for about 58% of the total export of plant extracts in China Since 2006, they have implemented more stringent new CGMP regulations for dietary supplements As the quality standards of plant extracts (including pesticide residues, heavy metals and microbial colonies) implemented by developed countries such as Europe, America and Japan are very strict, domestic plant extraction enterprises are under great pressure The biggest shock to the plant extract industry at the beginning of 2012 was the adjustment of the legal inspection catalogue by the General Administration of customs and the General Administration of quality supervision, inspection and Quarantine of the people's Republic of China In response, Mr Xia, a senior pharmaceutical engineer of a pharmaceutical enterprise in Guangdong Province, expressed frustration to reporters: "because there is no standard to follow, China's plant extract export enterprises have been following customer standards and can only passively produce according to customer requirements." Liu Zhanglin also expressed great concern about this situation: "although the operation is simple according to the requirements of the other party, the disadvantages are obvious Once the customer raises an objection to the product quality, the production enterprise will be controlled by others and suffer losses There are numerous enterprises that suffer losses " At the same time, it is pointed out that in order to break through the technical barriers of developed countries, the export standards of plant extracts must be formulated and strictly implemented The promotion of healthy development benefits from the popularity of natural health concept In the global economic environment, despite the slowdown in export growth, the prospect of plant extract export is still optimistic in the future At present, there are hundreds of plant extracts produced in China, among which Ginkgo biloba extract, green tea extract and ginseng extract have been produced and exported on a large scale These products have a large market share in western countries "The international business standards of only 11 varieties are obviously not enough Due to the lack of standards, at present, China's plant lifting enterprises are very passive in export, time is pressing and the formulation procedures are cumbersome At present, it is necessary to make a large number of varieties with high demand first." In fact, although the standard formulation process is slow, the industry generally believes that China's plant extract industry is the most likely sub industry to achieve internationalization in the field of traditional Chinese medicine, and also a more realistic choice to achieve internationalization of traditional Chinese medicine "Facing the double pressure of the international and domestic market, the plant lifting enterprises should improve the overall level of the industry through product registration, unified standards, strengthen international certification and basic research, and improve innovation ability." Zhang Chengwen said It is reported that a few domestic enterprises have carried out some product certification work For example, Liaoning Dashi Pharmaceutical Co., Ltd., a joint venture with Germany, is the first Chinese wolfberry organic planting base that has passed the NOP certification in the United States and eec2092 / 91 certification in Europe, and its products have been sold to Europe and the United States However, USP certification (including dietary supplement certification, dietary supplement component certification and drug component certification) and EU cos certification (mainly for APIs) are relatively high, and only a few domestic enterprises have passed In addition, it is worth mentioning that plant extract products also play an increasingly important role in the big health industry chain As an "aggregate" of medicine, fine chemical industry and agriculture, plant extract industry is mainly used in functional factor, dietary supplement and functional food industry It is estimated that by 2015, the global market of functional factors, dietary supplements and functional food industry will reach US $250 billion, and the Chinese market will reach RMB 500 billion In the face of attractive prospects, domestic enterprises not only make full efforts in product quality, but also have an insight from the "price war" and start to dig into the market segments For example, Haotian in Xi'an mainly focuses on the Japanese market, mainly focusing on coenzyme Q10, inositol, anthocyanins, etc.; Chenguang Biology (300138, Guba) is mainly composed of natural pigment products, mainly including capsanthin and lutein, etc.; Ningbo lvzhijian is mainly composed of natural extract and effective ingredients of traditional Chinese medicine, including blueberry, blackcurrant, Ginkgo biloba, etc.; Beijing green gold is the largest extract enterprise in Beijing, mainly including licorice extract, blueberry extract, ginkgo flavone, etc Green tea extract, etc In addition, the fast-growing enterprises in recent years include Shanghai Fanzhi, Zhejiang Kangenbei (600572, Guba), Guilin Rhine, Chengdu Huagao, Jilin Hongjiu, Tianjin Jianfeng, etc "The introduction of international business standards is both an opportunity and a challenge for enterprises This time, it is proposed based on international standards, mainly for export and for the international market Next, it can be used for reference when formulating national standards " Liu Zhanglin revealed The international business standard for plant extracts issued in March 2013 includes 11 varieties, including bilberry extract, green tea extract, Ginkgo biloba extract, grape seed extract, silymarin extract, Polygonum cuspidatum extract, Centella asiatica extract, willow branch extract, human ginseng extract, hesperidin and rutin extract